George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 413.50
Bid: 414.00
Ask: 418.00
Change: 6.00 (1.47%)
Spread: 4.00 (0.966%)
Open: 411.00
High: 419.00
Low: 411.00
Prev. Close: 407.50
BNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Preferred securities contingently convertible

26 Sep 2017 17:13

RNS Number : 8906R
Banco Santander S.A.
26 September 2017
 

 

 

MATERIAL FACT

 

Banco Santander, S.A. ("Banco Santander" or the "Bank") informs that has carried out a placement of preferred securities contingently convertible into newly issued ordinary shares of the Bank, excluding pre-emptive subscription rights and for a nominal value of EUR 1,000,000,000 (the "Issue" and the "CCPS").

 

The Issue has been carried out through an accelerated bookbuilding process and has been targeted only at qualified investors.

 

The CCPS is issued at par and its remuneration, whose payment is subject to certain conditions and to the discretion of the Bank, has been set at 5.25% on an annual basis for the first six years. After that, it will be reviewed every five years by applying a margin of 499.9 basis points on the 5-year Mid-Swap Rate.

 

Banco Santander will request the European Central Bank to qualify the CPPS as additional tier 1 under the European Regulation 575/2013. The CPPS are perpetual although they may be called under certain circumstances and would be converted into newly issued ordinary shares of Banco Santander if the common equity Tier 1 (CET1) ratio of the Bank or its consolidated group, calculated in accordance with European Regulation 575/2013, were to fall below 5.125%. The CET1 pro forma of the Group (phased-in) was, as of 30 June 2017, of 12.076%.

 

An application will be made for the CCPS to be admitted to trading on the Global Exchange Market of the Irish Stock Exchange.

 

The Bank also informs that, as from today, the report drawn up by the directors of Banco Santander on the bases and rules for conversion the CCPS and the exclusion of preferential subscription rights and the report in connection therewith prepared by an independent expert, both in accordance with articles 414.2 and 417.2 of the Spanish Companies Law (Ley de Sociedades de Capital), will be available on the Bank´s website (www.santander.com). The indicated reports will also be reported to the shareholders at the first general shareholders´ meeting to be held following the Issue.

 

 

 

 

Boadilla del Monte (Madrid), 26 September 2017

 

IMPORTANT INFORMATION

This material fact does not constitute an offer to sell, or the solicitation of an offer to buy any securities, nor shall there be any sale of such securities in any state of the United States or in another jurisdiction in which such offer, solicitation or sale would not be permitted before registration or qualification under the securities laws of such state or jurisdiction. The securities described above have not been registered under the U.S. Securities Act of 1933, as amended, or any applicable securities laws of any other jurisdiction. Unless so registered, such securities may not be offered or sold in the United States or any other jurisdiction except pursuant to an exemption from the registration requirements of the U.S. Securities Act of 1933, as amended, and any applicable securities laws of such other jurisdiction.

This material fact does not constitute an offer document or an offer of transferable securities to the public in the United Kingdom to which section 85 of the Financial Services and Markets Act 2000 ("FSMA") applies and should not be considered as a recommendation that any person should subscribe for or purchase any of the securities described herein. These securities will not be offered or sold to any person in the United Kingdom except in circumstances which have not resulted and will not result in an offer to the public in the United Kingdom in contravention of section 85(1) of FSMA.

This material fact does not constitute an offer to the public in Italy of financial products, as defined under article 1, paragraph 1, letter (t) of legislative decree no. 58 of 24 February 1998, as amended (the "Financial Services Act"). The preferred securities cannot be offered or sold in the Republic of Italy to any natural persons nor to entities other than qualified investors (investitori qualificati) as defined pursuant to Article 100 of the Financial Services Act and Article 34-ter, paragraph 1, letter b) of Regulation No. 11971 of May 14, 1999, as amended (the "Issuers Regulations") issued by the Commissione Nazionale per le Società e la Borsa, the Italian securities and financial markets regulator ("CONSOB") or unless in circumstances which are exempt from the rules on public offers pursuant to Article 100 of the Financial Services Act and the implementing CONSOB regulations, including the Issuers Regulations. This material fact is for informational purposes only and does not constitute and shall not, in any circumstances, constitute a public offering or an invitation to the public in connection with any offer within the meaning of the Directive 2003/71/EC of the European Parliament and of the Council of 4 November 2003 on the prospectus to be published when securities are offered to the public or admitted to trading.

No action has been made or will be taken that would permit a public offering of any securities described herein in any jurisdiction in which action for that purpose is required. No offers, sales, resales or delivery of any securities described herein or distribution of any offering material relating to any such securities may be made in or from any jurisdiction except in circumstances which will result in compliance with any applicable laws and regulations and which will not impose any obligation on the Bank or the joint lead managers of the Issue or any of their respective affiliates. Additionally, the CCPS will not be offered, distributed or sold in Spain nor to Spanish residents.

This material fact is an announcement and not a prospectus and investors should not subscribe for or purchase any securities referred herein except on the basis of the information in the offering circular.

Restrictions on Marketing and Sales to Retail Investors

The preferred securities are not intended to be sold and should not be sold to retail clients in the European Economic Area, as defined in the rules set out in the Product Intervention (Contingent Convertible Instruments and Mutual Society Shares) Instrument 2015 (as amended or replaced from time to time) (the "PI Rules") other than in circumstances that do not and will not give rise to a contravention of those rules by any person. By making or accepting an offer to purchase any preferred securities from the Issuer or the Joint Lead Managers, each prospective investor will be deemed to have represented, warranted, and undertaken to the Issuer and each of the Joint Lead Managers that (i) it is not a retail client; and (ii) it will not take any action which would result in a breach by the Issuer or any other person of the PI Rules (as defined herein). Potential investors should read the whole of the related offering circular, in particular the "Risk Factors" section and the "Restrictions on Marketing and Sales to Retail Investors" section.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCQQLFLDKFFBBL
Date   Source Headline
12th Apr 202311:04 amRNSBuyback programme: transactions 30 March -11 April
11th Apr 20237:00 amRNSFurther re Santander Mexico tender offer: results
31st Mar 20232:28 pmRNS2023 AGM - Resolutions
31st Mar 202312:11 pmRNSTotal Voting Rights
31st Mar 20237:35 amRNSSantander to confirm its targets for 2023 at AGM
30th Mar 202311:05 amRNSBuyback programme: transactions 23 - 29 March
23rd Mar 202311:40 amRNSDirector/PDMR Shareholding
23rd Mar 202310:22 amRNSBuyback programme: transactions 16 - 22 March
21st Mar 20231:04 pmRNSFurther re capital reduction
17th Mar 202312:21 pmRNSDirector/PDMR Shareholding
16th Mar 20235:16 pmRNSTotal Voting Rights
16th Mar 202311:18 amRNSCapital reduction (buy-back programme shares)
16th Mar 202311:09 amRNSBuyback programme: transactions 9 - 15 March
10th Mar 20239:55 amRNS2022 UK Annual Report
9th Mar 20234:27 pmRNSDirector/PDMR Shareholding
9th Mar 202311:39 amRNSBuyback programme: transactions 1 - 8 March
6th Mar 20233:02 pmRNSDirector/PDMR Shareholding
6th Mar 20232:59 pmRNSDirector/PDMR Shareholding
28th Feb 20235:27 pmRNSNotice of AGM
28th Feb 202312:23 pmRNSTotal Voting Rights
28th Feb 20239:51 amRNSInvestor Day: Group CFO presentation
28th Feb 20238:33 amRNSInvestor Day: Group CEO presentation
28th Feb 20238:05 amRNSInvestor Day: Executive chair presentation
28th Feb 20237:00 amRNSPayout policy, strategic plans & profit forecasts
28th Feb 20237:00 amRNSExecution of 2022 shareholder remuneration policy
24th Feb 20237:00 amRNSDirector/PDMR Shareholding
21st Feb 202310:58 amRNSInvestor Day meeting announcement
17th Feb 20231:33 pmRNSDirector/PDMR Shareholding
7th Feb 202311:24 amRNSTender Offer
2nd Feb 20237:00 amRNS2022 Financial report & Earnings presentation
2nd Feb 20237:00 amRNS2022 Results - Press release
1st Feb 202311:06 amRNSEnd of the Programme & 26 -31 Jan Transactions
31st Jan 20233:22 pmRNSTotal Voting Rights
26th Jan 202311:08 amRNSNotice of 2022 Results
26th Jan 202311:03 amRNSBuyback programme: transactions 19 - 25 January
19th Jan 202311:14 amRNSBuyback programme: transactions 12 - 18 January
12th Jan 202311:29 amRNSBuyback programme: transactions 5 - 11 January
5th Jan 202311:14 amRNSBuyback programme: transactions 29 Dec- 4 Jan
30th Dec 202212:18 pmRNSTotal Voting Rights
29th Dec 202211:06 amRNSBuyback programme: transactions 21- 28 December
28th Dec 20227:00 amRNSTotal Voting Rights
28th Dec 20227:00 amRNSDirector/PDMR Shareholding
28th Dec 20227:00 amRNSDirector/PDMR Shareholding
23rd Dec 202211:33 amRNSTotal early redemption of mortgage covered bonds
22nd Dec 202210:17 amRNSSREP Capital Requirements 2023
21st Dec 20224:59 pmRNSDirector/PDMR Shareholding
21st Dec 202211:14 amRNSBuyback programme: transactions 12- 20 December
12th Dec 202211:06 amRNSTransaction in Own Shares
12th Dec 20227:00 amRNSDirectorate Change
1st Dec 20225:20 pmRNSBuyback programme: transactions 22 - 30 November

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.